- Home
- VYGR vs SRFM Comparison
VYGR vs SRFM Comparison
Compare VYGR & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- SRFM
- Stock Information
- Founded
- VYGR 2013
- SRFM 2011
- Country
- VYGR United States
- SRFM United States
- Employees
- VYGR N/A
- SRFM N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- VYGR Health Care
- SRFM Consumer Discretionary
- Exchange
- VYGR Nasdaq
- SRFM Nasdaq
- Market Cap
- VYGR 172.6M
- SRFM 199.2M
- IPO Year
- VYGR 2015
- SRFM 2023
- Fundamental
- Price
- VYGR $3.19
- SRFM $4.18
- Analyst Decision
- VYGR Strong Buy
- SRFM Buy
- Analyst Count
- VYGR 8
- SRFM 4
- Target Price
- VYGR $14.33
- SRFM $5.56
- AVG Volume (30 Days)
- VYGR 647.7K
- SRFM 11.0M
- Earning Date
- VYGR 08-12-2025
- SRFM 08-12-2025
- Dividend Yield
- VYGR N/A
- SRFM N/A
- EPS Growth
- VYGR N/A
- SRFM N/A
- EPS
- VYGR N/A
- SRFM N/A
- Revenue
- VYGR $66,958,000.00
- SRFM $112,307,000.00
- Revenue This Year
- VYGR N/A
- SRFM N/A
- Revenue Next Year
- VYGR $78.89
- SRFM $62.23
- P/E Ratio
- VYGR N/A
- SRFM N/A
- Revenue Growth
- VYGR N/A
- SRFM 31.17
- 52 Week Low
- VYGR $2.65
- SRFM $0.90
- 52 Week High
- VYGR $9.55
- SRFM $9.91
- Technical
- Relative Strength Index (RSI)
- VYGR 48.20
- SRFM 45.06
- Support Level
- VYGR $3.15
- SRFM $4.50
- Resistance Level
- VYGR $3.79
- SRFM $5.95
- Average True Range (ATR)
- VYGR 0.21
- SRFM 0.84
- MACD
- VYGR 0.00
- SRFM -0.30
- Stochastic Oscillator
- VYGR 16.67
- SRFM 1.15
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.